Abstract
We use recent data and research results and a probabilistic model to estimate the chance that an air traveler in coach will contract Covid-19 on a US domestic jet flight two hours long, both when all coach seats are full and when all but middle seats are full. The point estimates we reach based on data from late September 2020 are about 1 in 3,900 for full flights and 1 in 6,400 when middle seats are kept empty. These estimates are subject to substantial uncertainty, with factor-of-three or greater margins of error. However, because uncertainties in key parameters affect both risk estimates the same way, they leave the relative risk ratio for “fill all seats” compared to “middle seat open” close to 1.64 (i.e., close to (1/3,900)/(1/6,400). We compare the infection risks over a two-hour flight to those of two hours on the ground, and find that the flight presents greater hazard. We also approximate the mortality risks caused by Covid-19 infections contracted on airplanes, taking into account that infected passengers can in turn infect others not on the plane. The point estimates for death risk are low—averaging about one death per 800,000 passengers--but they are somewhat higher than those associated with plane crashes and aviation terrorism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No such body has considered the work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The revision is more explicit about the assumptions underlying the calculations, and is tied more closely to the rapidly evolving literature about the risks that Covid-19 poses to air travelers.
Data Availability
All data are readily available in public sources, like new confirmed Covid-19 cases by day in US states. These sources are identified in the paper.
